The creation of Voxcan results from the following observations made in 2007 by the founding partners regarding the difficulties and constraints linked to carrying out preclinical studies:
Initially based at Lyon Veterinary School, the founding partners aimed to accelerate preclinical studies by using the latest cutting-edge technologies, with Preclinical Medical Imaging ensuring longitudinal monitoring of compound efficacy and biodistribution while reducing animal numbers, as well as measurements based on multiplex analysis (flow cytometry, luminex, qPCR).
In 2016, to meet an increasing demand for preclinical services, Voxcan developed its own facilities on a brand-new site while keeping its exact same philosophy.
To ensure Scientific Excellence, we recruit and train qualified experts (PhD) in our fields of activity, with regular participation in collaborative research projects to provide cutting-edge services.
At Voxcan, we are fully committed to ensuring efficient and reproducible research, by performing preclinical studies at GLP-levels and maintaining high quality standards thanks to our dedicated Quality Assurance system.
In addition to being compliant with the 3Rs and applicable legislation, Voxcan strives to improve animal welfare and ethical standards, with its own Internal Ethics committee and Animal Welfare Research Committee.